Cambridge Innovation Capital (CIC) is a leading venture capital investor backing and building category-leading deep tech and life sciences companies.

Our focus on the Cambridge ecosystem, and privileged relationship with the University of Cambridge, provides us with unparalleled access to emerging opportunities in one of Europe’s leading innovation hubs.

We have raised in excess of £0.5 billion from a geographically diverse range of institutional and strategic investors and have invested in 40 companies, whose innovations are set to transform the lives of many. Through these investments, we are helping to guide the development of disruptive companies in fields as diverse as cancer therapy, genomic diagnosis, surgical robotics, artificial intelligence and quantum computing.

Our commercial objective of creating value is central to our business, but our motivation is broader. We are driven by a desire to use our expertise to support companies and the wider innovation ecosystem to impact society positively.

Read our Annual Review at the link below.